-
As a result of an investigation by the Centers for Disease Control and Prevention (CDC) into a recent outbreak of carbapenem-resistant Enterobacteriaceae (CRE), Advocate Lutheran General Hospital in Park Ridge, IL, changed endoscopic retrograde cholangiopancreatography (ERCP) endoscope reprocessing from automated high-level disinfection to gas sterilization in September 2013.
-
Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery (MIS) nationally for patients with pancreatic disease. Although adaptation of MIS for this difficult-to-reach gland is recent, the growing trend points to improved patient outcomes, such as reduced bleeding and infections.
-
-
An upper endoscopy procedure performed on some half million patients annually in the United States might pose risk for transmission of the emerging New Delhi variety of carbapenem-resistant Enterobacteriaceae (CRE), even if current cleaning and high level disinfection protocols are followed.
-
In a study looking at discussions held between pediatricians and family medicine physicians and teen-age patients, results show less than two-thirds of such interactions included talk about sex, sexuality, or dating during annual visits.
-
Declining resources in the face of increasing demand are causing sexually transmitted infection (STI) clinics to review new strategies to maximize efficiency without compromising quality of care.
-
New research indicates that provision of effective contraception at the time of postpartum follow-up is a key strategy for achieving optimal interpregnancy intervals.
-
-
The American College of Obstetricians and Gynecologists says that long-acting reversible contraception (LARC) methods are safe, effective, and appropriate options for teens, but some might perceive high discontinuation rates among younger women and therefore steer patients away from them.
-
Transdermal contraception provides a family planning option that is not dependent on daily dosing. The only transdermal contraceptive approved in the United States is the Ortho Evra patch.
